Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

Clinical trial NCT01366612 · TERMINATED

Trial details

NCT number: NCT01366612
Sponsor: Hackensack Meridian Health
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Myeloid Malignancies Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myeloproliferative Disorders Myelodysplastic Syndrome

Start date: 2010-06-16
Primary completion: 2020-08-17
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.